FRAGMIN DIN 02352648
Health Canada record
| Active ingredient(s) | DALTEPARIN SODIUM 7500 UNIT |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B01AB04 DALTEPARIN |
| Original market date | 01-Feb-2011 |
| Current status date | 01-Feb-2011 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DALTEPARIN SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02494582 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 16500 UNIT | Marketed |
| 02132648 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 5000 UNIT | Marketed |
| 02352680 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 18000 UNIT | Marketed |
| 02430789 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 3500 UNIT | Marketed |
| 02132621 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 2500 UNIT | Marketed |
| 02231171 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 25000 UNIT | Marketed |
| 02352656 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 10000 UNIT | Marketed |
| 02352664 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 12500 UNIT | Marketed |
| 02352672 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 15000 UNIT | Marketed |
| 02132664 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 10000 UNIT | Cancelled Post Market |
| 02377454 | FRAGMIN | PFIZER CANADA ULC | Solution | DALTEPARIN SODIUM 2500 UNIT | Cancelled Post Market |
| 02132656 | FRAGMIN INJ.-LIQ 2500 IU(ANTI-XA)/ML | PHARMACIA & UPJOHN INC | Liquid | DALTEPARIN SODIUM 2500 UNIT | Cancelled Post Market |
International API supply for DALTEPARIN SODIUM
2 active FDA Drug Master Files.
Request a quote for FRAGMIN